Phreesia, Inc. (0A23.L)
USD 25.52
(2.82%)
USD 25.52
(2.82%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 11.98 Million USD | 30.53% |
| 2023 | 9.18 Million USD | -41.9% |
| 2022 | 15.8 Million USD | 10.33% |
| 2021 | 14.32 Million USD | -39.99% |
| 2020 | 23.86 Million USD | -26.08% |
| 2019 | 32.28 Million USD | 40.77% |
| 2018 | 22.93 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 11.98 Million USD | -16.45% |
| 2024 FY | 11.98 Million USD | 30.53% |
| 2024 Q1 | 14.62 Million USD | 59.26% |
| 2024 Q2 | 15.79 Million USD | 8.06% |
| 2024 Q3 | 14.34 Million USD | -9.22% |
| 2023 Q1 | 14.35 Million USD | -9.18% |
| 2023 Q4 | 9.18 Million USD | -15.42% |
| 2023 FY | 9.18 Million USD | -41.9% |
| 2023 Q3 | 10.85 Million USD | -13.73% |
| 2023 Q2 | 12.58 Million USD | -12.33% |
| 2022 Q2 | 12.63 Million USD | 1.19% |
| 2022 Q4 | 15.8 Million USD | 32.07% |
| 2022 Q3 | 11.96 Million USD | -5.33% |
| 2022 Q1 | 12.48 Million USD | -12.79% |
| 2022 FY | 15.8 Million USD | 10.33% |
| 2021 FY | 14.32 Million USD | -39.99% |
| 2021 Q1 | 27.06 Million USD | 13.4% |
| 2021 Q2 | 30.68 Million USD | 13.39% |
| 2021 Q3 | 32.6 Million USD | 6.26% |
| 2021 Q4 | 14.32 Million USD | -56.08% |
| 2020 Q1 | 37.97 Million USD | 17.63% |
| 2020 FY | 23.86 Million USD | -26.08% |
| 2020 Q2 | 23.82 Million USD | -37.27% |
| 2020 Q4 | 23.86 Million USD | 0.53% |
| 2020 Q3 | 23.73 Million USD | -0.36% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | 32.28 Million USD | 0.0% |
| 2019 FY | 32.28 Million USD | 40.77% |
| 2018 FY | 22.93 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Accuray Incorporated | 172.15 Million USD | 93.039% |
| Align Technology, Inc. | 96.96 Million USD | 87.642% |
| Elevance Health Inc. | 25.12 Billion USD | 99.952% |
| AxoGen, Inc. | 69.29 Million USD | 82.707% |
| Boston Scientific Corporation | 9.09 Billion USD | 99.868% |
| CVS Health Corporation | 79.38 Billion USD | 99.985% |
| Cardinal Health, Inc. | 5.6 Billion USD | 99.786% |
| Centene Corporation | 17.69 Billion USD | 99.932% |
| DaVita Inc. | 11.11 Billion USD | 99.892% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 99.971% |
| Hologic, Inc. | 2.53 Billion USD | 99.527% |
| Humana Inc. | 10.21 Billion USD | 99.883% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | 98.736% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | 99.799% |
| Masimo Corporation | 970 Million USD | 98.765% |
| McKesson Corporation | 5.47 Billion USD | 99.781% |
| Patterson Companies, Inc. | 762.94 Million USD | 98.429% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | 99.777% |
| ResMed Inc. | 873.93 Million USD | 98.629% |
| Henry Schein, Inc. | 2.74 Billion USD | 99.563% |
| Teladoc Health, Inc. | 1.59 Billion USD | 99.247% |
| Universal Health Services, Inc. | 5.36 Billion USD | 99.777% |
| Veeva Systems Inc. | 55.77 Million USD | 78.515% |
| Baxter International Inc. | 14.36 Billion USD | 99.917% |
| Becton, Dickinson and Company | 15.87 Billion USD | 99.925% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 86.656% |
| Danaher Corporation | 19.35 Billion USD | 99.938% |
| Stryker Corporation | 12.99 Billion USD | 99.908% |
| Medtronic plc | 24.96 Billion USD | 99.952% |